NCT00440011View on ClinicalTrials.gov

Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%

PHASE4CompletedINTERVENTIONAL

Enrollment

266

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions

GlaucomaOcular Hypertension

Interventions

DRUG

bimatoprost 0.03% eye drops

bimatoprost 0.03% 1 drop nightly for 3 months

DRUG

travoprost 0.004% eye drops

travoprost 0.004% 1 drop nightly for 3 months

Trial Locations (1)

Unknown

San Diego

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Allergan

INDUSTRY